Sention Inc.

First-in-class CNS drugs 2530 Meridian Parkway Suite 300 Durham, NC 27713 Phone: (919) 806-4304 Fax: (919) 806-4301 Web Site: www.colucid.com Contact: James F. White, PhD, CEO Industry Segment: Ph

When Greg Gardiner, PhD, looked closely at Bionaut Pharmaceuticals Inc. last November, he saw a problem right away. The start-up was using the proprietary assay system around which it was founded t

The Food and Drug Administration's intimation to Eli Lilly & Co. in late January that the regulator wouldn't approve Lilly's serotonin and norepinephrine reuptake inhibitor (SNRI) duloxetine as a t

The business problem with ideas is that they're often unprotectable. That's why drug companies have always preferred to create things —or, in intellectual property parlance, compositions of matter. P